152 related articles for article (PubMed ID: 11714090)
1. The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formation.
Girard TJ; Nicholson NS
Curr Opin Pharmacol; 2001 Apr; 1(2):159-63. PubMed ID: 11714090
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor - a therapeutic target for thrombotic disorders.
Houston DS
Expert Opin Ther Targets; 2002 Apr; 6(2):159-74. PubMed ID: 12223078
[TBL] [Abstract][Full Text] [Related]
3. [Biology and physiopathology of tissue factor and its relevance for cardiovascular diseases].
Del Turco S; De Caterina R
Ital Heart J Suppl; 2003 Jul; 4(7):559-68. PubMed ID: 14558284
[TBL] [Abstract][Full Text] [Related]
4. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Factor VIIa/tissue factor.
Shirk RA; Vlasuk GP
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
[TBL] [Abstract][Full Text] [Related]
6. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
Lee AY; Vlasuk GP
J Intern Med; 2003 Oct; 254(4):313-21. PubMed ID: 12974870
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
[TBL] [Abstract][Full Text] [Related]
8. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
[TBL] [Abstract][Full Text] [Related]
9. Recent research developments in the direct inhibition of coagulation proteinases--inhibitors of the initiation phase.
Henry BL; Desai UR
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):323-36. PubMed ID: 18855645
[TBL] [Abstract][Full Text] [Related]
10. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.
Kranjc A; Kikelj D; Peterlin-Masic L
Curr Pharm Des; 2005; 11(32):4207-27. PubMed ID: 16375741
[TBL] [Abstract][Full Text] [Related]
12. An anti-tissue factor monoclonal antibody which inhibits TF.VIIa complex is a potent anticoagulant in plasma.
Ruf W; Edgington TS
Thromb Haemost; 1991 Nov; 66(5):529-33. PubMed ID: 1803616
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor-fVIIa inhibition: update on an unfinished quest for a novel oral antithrombotic.
Priestley ES
Drug Discov Today; 2014 Sep; 19(9):1440-4. PubMed ID: 24881783
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor and coronary artery disease.
Moons AH; Levi M; Peters RJ
Cardiovasc Res; 2002 Feb; 53(2):313-25. PubMed ID: 11827681
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.
Chi L; Gibson G; Peng YW; Bousley R; Brammer D; Rekhter M; Chen J; Leadley R
J Thromb Haemost; 2004 Jan; 2(1):85-92. PubMed ID: 14717971
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Ott I; Weigand B; Michl R; Seitz I; Sabbari-Erfani N; Neumann FJ; Schömig A
Circulation; 2005 Jan; 111(3):349-55. PubMed ID: 15642762
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Suleymanov OD; Szalony JA; Salyers AK; LaChance RM; Parlow JJ; South MS; Wood RS; Nicholson NS
J Pharmacol Exp Ther; 2003 Sep; 306(3):1115-21. PubMed ID: 12829728
[TBL] [Abstract][Full Text] [Related]
19. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
20. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Frédérick R; Pochet L; Charlier C; Masereel B
Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
